يعرض 1 - 20 نتائج من 79 نتيجة بحث عن '"antibody-based therapy"', وقت الاستعلام: 0.59s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
  4. 4
  5. 5
    Academic Journal

    المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut régional de Cancérologie de Montpellier (ICM), Centre National de la Recherche Scientifique (CNRS), Inserm Transfert, Université de Montpellier, Région Occitanie, Ligue Nationale contre le Cancer, Ligue départementale du Gard, Ligue départementale de l'Hérault, Ligue départementale de Charente Maritime, ANR-22-PEBI-0009,ACCREDIA,ACCelerating Research for Early Development of Innovative Antibodies(2022)

    المصدر: ISSN: 0007-1188.

  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Francesco Ferrari, Pier, Trucillo, Paolo, De Negri Atanasio, Giulia, Bufalini, Chiara, Campardelli, Roberta, Perego, Patrizia, Palombo, Domenico, Reverchon, Ernesto

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000959587200001; volume:11; issue:3; firstpage:663; numberofpages:13; journal:PROCESSES; https://hdl.handle.net/11588/915621; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85152007981; https://www.mdpi.com/2227-9717/11/3/663

  8. 8
    Academic Journal

    المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle (ICM), CRLCC Val d'Aurelle - Paul Lamarque, Hôpital Universitaire Carémeau Nîmes (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut régional de Cancérologie de Montpellier (ICM), Centre National de la Recherche Scientifique (CNRS), This work was supported by a public grant overseen by the French National Research Agency (ANR) as part of the “Investissements d’Avenir” program (reference: LabEx MabImprove ANR-10-LABX-53-01), University of Montpellier, Inserm Transfert, Région Occitanie, ‘Ligue Nationale contre le Cancer’, the associations ‘Ligue Régionale du Gard’, ‘Ligue Régionale de l’Herault’, and ‘Ligue Régionale de la Charente Maritime. We acknowledge the “Réseau d’Histologie Expérimentale de Montpellier” - RHEM facility supported by SIRIC Montpellier Cancer Grant INCa_Inserm_DGOS_12553, the European regional development foundation and the Occitanie region (FEDER-FSE 2014-2020 Languedoc Roussillon), REACT-EU (Recovery Assistance for Cohesion and the Territories of Europe), IBiSA and Ligue contre le cancer for processing/analyzing our animal tissues with expertise.

    المصدر: ISSN: 0007-1188.

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal

    المصدر: International Journal of Molecular Sciences; Volume 21; Issue 11; Pages: 4067

    مصطلحات موضوعية: PDAC, mesothelin, CAR T-cells, antibody-based therapy, vaccines

    جغرافية الموضوع: agris

    وصف الملف: application/pdf

    Relation: Molecular Pathology, Diagnostics, and Therapeutics; https://dx.doi.org/10.3390/ijms21114067

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
  19. 19
  20. 20

    المصدر: International Journal of Molecular Sciences
    International Journal of Molecular Sciences, Vol 21, Iss 4067, p 4067 (2020)